Physician profile
Gayla M Royer
NPI 1003819632
$1,499.89
in general payments reported to CMS, 2019-2025
16 companies · $526 in 2025
The $526 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $114 · 2021: $127 · 2022: $28.63 · 2023: $245 · 2024: $459 · 2025: $526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,209 · Education: $21.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,208.68 |
| Education | $21.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $413.53 | 2023-2025 | Xtampza |
| Scilex Pharmaceuticals INC. | $211.69 | 2023-2025 | Ztlido |
| Boston Scientific Corporation | $203.47 | 2023-2025 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $171.22 | 2024-2025 | |
| Lilly USA, LLC | $131.61 | 2020-2021 | |
| Novo Nordisk INC | $95.25 | 2020-2021 | |
| Abbott Laboratories | $59.26 | 2024-2025 | Proclaim |
| Glaxosmithkline, LLC. | $43.35 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.12 | 2025 | Relistor |
| Indivior INC. | $32.81 | 2025 | Sublocade |
| Hikma Pharmaceuticals USA | $21.00 | 2023 | Kloxxado |
| Si-Bone, INC. | $20.28 | 2025 | |
| Braeburn INC. | $18.08 | 2024 | Brixadi |
| Saluda Medical Americas, INC. | $16.10 | 2025 | Evoke |
| Almatica Pharma LLC | $15.26 | 2023 | Gralise |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $12.86 | 2023 | Horizant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gayla Royer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.